Mymetics Corp (MYMX): Villanger: In-vivo use of SIVmac239 with...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Re: bow-tie post# 16609

Sunday, 03/01/2020 8:20:03 PM

Sunday, March 01, 2020 8:20:03 PM

Villanger: In-vivo use of SIVmac239 with a reversing stop codon in the SIV nef gene

https://journals.lww.com/aidsonline/Citation/2020/03010/In_vivo_use_of_SIVmac239_with_a_reversing_stop.18.aspx

Keep Last Read

Replies (1) Next 10 Prev Next

Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 01/02/2024 06:16:20 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 01:00:38 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/13/2023 05:15:20 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 01:53:34 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2023 08:42:46 PM
Form SC 13E3 - Going private transaction by certain issuers • Edgar (US Regulatory) • 10/17/2023 07:08:56 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 01:00:41 PM

InvestorsHub NewsWire

Only $200 per official company press release!